"Will Prognostic and Predictive Biomarkers Be Useful Tools in Cancer Disparities?"
Tuesday, April 8, 2014
10:30 a.m. – 12:30 p.m.
Room 1, San Diego Convention Center
Co-Chairs: Rick A. Kittles, Ph.D., and Edith A. Perez, M.D.
Our current focus on the molecular characterization of cancer genomic signatures continues to provide important insight for personalized treatments. These emerging biomarkers provide prognostic and predictive information on overall outcome and/or best targeted therapy based on tumor signatures. Will understanding genomic variation of a tumor improve outcomes and provide insight on high risk individuals within specific ethnic groups? The purpose of this session is to address recent advances in the identification of prognostic and predictive biomarkers, their utility in Personalized Oncology, and potential impact on cancer disparities.
Introduction of program
Co-Chair, Rick A. Kittles, Ph.D.
University of Illinois at Chicago, Chicago, IL
Novel markers for childhood ALL in ethnically diverse populations
Jun Yang, Ph.D.
St. Jude Children's Research Hospital, Memphis TN
Racial aspects of DNA mismatch repair effects in colon cancer
John M. Carethers, M.D.
University of Michigan, Ann Arbor, MI
Genomic markers for predictive testing of breast cancer
Lyndsay Harris, M.D.
Univ. Hospitals Seidman Cancer Ctr. at UH Case Medical Ctr., Cleveland, OH
Co-Chair, Edith A. Perez, M.D.
Mayo Clinic, Jacksonville, FL
Back to top